Japan Medical Dynamic Marketing, INC. Stock

Equities

7600

JP3689100000

Medical Equipment, Supplies & Distribution

Delayed Japan Exchange 10:17:05 2024-05-28 pm EDT 5-day change 1st Jan Change
615 JPY -1.13% Intraday chart for Japan Medical Dynamic Marketing, INC. -0.81% -18.97%
Sales 2022 19.19B 122M Sales 2023 21.31B 135M Capitalization 27.38B 174M
Net income 2022 2.14B 13.57M Net income 2023 1.42B 9.05M EV / Sales 2022 2.21 x
Net cash position 2022 743M 4.72M Net cash position 2023 934M 5.94M EV / Sales 2023 1.24 x
P/E ratio 2022
20.2 x
P/E ratio 2023
19.3 x
Employees 488
Yield 2022
0.73%
Yield 2023
1.25%
Free-Float 56.39%
More Fundamentals * Assessed data
Dynamic Chart
Japan Medical Dynamic Marketing, Inc. Provides Year-End Dividend Guidance for the Year Ending March 31, 2024 CI
Japan Medical Dynamic Marketing, INC. Provides Earnings Guidance for the Year Ending March 31, 2024 CI
Japan Medical Dynamic Marketing, INC. Provides Year-End Dividend Guidance for the Year Ending March 31, 2024 CI
Japan Medical Dynamic Marketing, INC. Provides Consolidated Earnings Guidance for the First Half and Year Ending March 31, 2024 CI
Japan Medical Dynamic Marketing, INC. Provides Dividend Guidance for the Year Ending March 31, 2024 CI
Japan Medical Dynamic Marketing's Fiscal Full-Year Net Income Falls Over 33%; Shares Slip 5% MT
Japan Medical Dynamic Marketing, INC. Provides Consolidated Earnings Guidance for the First Half and Year Ending March 31, 2024 CI
Japan Medical Dynamic Marketing, INC. Announces Dividend for the Year Ended March 31, 2023, Payable on June 26, 2023; Provides Dividend Guidance for the Year Ending March 31, 2024 CI
Japan Medical Dynamic Marketing, INC. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023 CI
Japan Medical Dynamic Marketing, INC. Provides Year End Dividend Guidance for the Year Ending March 31, 2023 CI
Japan Medical Dynamic Marketing, INC. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023 CI
Japan Medical Dynamic Marketing, INC. Provides Year End Dividend Guidance for the Year Ending March 31, 2023 CI
Japan Medical Dynamic Marketing, INC. Consolidated Provides Earnings Guidance for the Fiscal First Half of 2023 and Full Year Ending March 31, 2023 CI
Japan Medical Dynamic Marketing, INC. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023 CI
Japan Medical Dynamic Marketing, INC. Provides Consolidated Earnings Guidance for the Six Months and Fiscal Year Ending March 31, 2023 CI
More news
1 day-1.13%
1 week-0.81%
Current month-8.89%
1 month-8.89%
3 months-14.82%
6 months-12.89%
Current year-18.97%
More quotes
1 week
610.00
Extreme 610
635.00
1 month
610.00
Extreme 610
687.00
Current year
610.00
Extreme 610
791.00
1 year
610.00
Extreme 610
1 082.00
3 years
610.00
Extreme 610
2 500.00
5 years
610.00
Extreme 610
2 623.00
10 years
276.00
Extreme 276
2 623.00
More quotes
Managers TitleAgeSince
Director of Finance/CFO - -
President 67 01-07-31
Chief Administrative Officer 61 16-05-31
Members of the board TitleAgeSince
Comptroller/Controller/Auditor 64 84-02-29
Director/Board Member 60 88-11-30
Director/Board Member 74 15-05-31
More insiders
Date Price Change Volume
24-05-28 615 -1.13% 24 300
24-05-28 622 -1.74% 57,400
24-05-27 633 +0.16% 27,500
24-05-24 632 +1.44% 35,200
24-05-23 623 +0.48% 34,600

Delayed Quote Japan Exchange, May 28, 2024 at 10:17 pm EDT

More quotes
Japan Medical Dynamic Marketing, INC. is a Japan-based medical equipment provider. The Company is principally engaged in the import, development, manufacture and sale of medical equipment primarily in the field of orthopedic surgery. The Company has two segments. The Japan segment imports materials for osteosynthesis, artificial joints and spinal fixation devices from manufacturers, and sell them in Japan. The America segment is involved in the development and manufacture of materials for osteosynthesis, artificial joints, spinal fixation devices and other products, as well as the sale of medical equipment in North America. As of March 31, 2014, the Company had one subsidiary in the United States.
More about the company